Musi wa28 Kukadzi 2026, National Medical Products Administration (NMPA) yakabvumidza zviri pamutemo kutengeswa kweJMKX001899 sulfate yekurapa varwere vakuru vane KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC) avo vakamborapwa kamwe chete kare.
JMKX001899 mushonga unosarudza KRAS G12C uye wakambopiwa zita rekuti "Breakthrough Therapy" kubva kuNMPA.
Ruzivo rwakakosha rwekiriniki runokurudzira:
- Chiyero chekupindura chakanangana (ORR) chakasvika pa55.2%
- Huwandu hwemwedzi gumi nemiviri yekurarama (OS) hwasvika 60.4%
Pamusoro peruzivo rwakanaka rwekubatsira murwere kurarama, JMKX001899 inoitawo kuti mishonga yemurwere ibudirire, ichitora mushonga wekuti "kamwe chete pazuva, mapiritsi maviri nguva imwe neimwe," uye inoshivirira zvakanaka, nokudaro ichivandudza kutevedzera kwemurwere kwenguva refu.
Parizvino, zvidzidzo zvekiriniki zvemushonga uyu zviri kuitwawo kuvarwere vane bundu rakasimba rakadai sekenza yemudumbu ine mutations yeKRAS G12C, ine mukana wekubatsira mhando dzakawanda dzevarwere vekenza mune ramangwana.
**Sei uchifanira kusarudza Dhipatimendi reBeijing South Region Oncology Hospital International?**
- **Tekinoroji Yekurapa Yepamusoro-soro:** Tinoramba tichiziva nezvekufambira mberi kuri kuitwa pasi rose mukurapa kenza uye tiri pakati pevekutanga kuunza mishonga mitsva nekurapa, kusanganisira JMKX001899.
- **Chikwata Chenyanzvi Dzine Nyanzvi Dzakawanda:** Chikwata chedu chekupa mazano chinosanganisira nyanzvi dzekenza dzine ruzivo, vanachiremba veX-ray, uye vanachiremba vezvirwere vanogadzira zvirongwa zvekurapa murwere wega wega.
- **Basa Rinoitirwa Pamwe Chete:** Kubva pakubvunzana kwekutanga uye kuongororwa kwemajini kusvika pakugadzira hurongwa hwekurapa, nhungamiro yemishonga, uye manejimendi ekutevera, tinopa masevhisi ekurapa asina matambudziko, ekupedzisira.
- **Nzvimbo Yekurapwa Pasi Pose:** Takashongedzerwa nezvipatara zvepamusoro, tinogadzira nzvimbo inodziya uye yakasununguka yekurapa uye tinoremekedza zvinodiwa nevarwere vanobva kwakasiyana-siyana.
- **Mabasa Ekutsigira Mitauro:** Tinopa mabasa ekushandura mitauro yakasiyana-siyana kubvisa zvipingamupinyi zvekutaurirana uye kuona kuti vanachiremba nevarwere vataurirana nemazvo.
**Tibatei Iye Zvino Kuti Muwane Sarudzo Dzekurapa Dzakanakisisa**
Kana iwe kana mudiwa wako muchitarisana nedambudziko reKRAS G12C-mutated advanced non-small cell lung cancer, ndapota inzwa wakasununguka kubata International Department of Beijing South Region Oncology Hospital. Chikwata chedu chehunyanzvi chichakupa mazano akadzama ekurapa uye rubatsiro rwekutsvaga rubatsiro rwekurapwa muChina.
- Kubvunzana Nefoni: 400-880-3716
- Kubvunzana paWeChat: 17801183037
- Email:
- 100085_010@163.com
- myimmnet@163.com
**Mibvunzo Inowanzo bvunzwa**
**M: Varwere vekune dzimwe nyika vanogona sei kuronga mabasa ekurapa kuBeijing South Region Oncology Hospital International Department?**
**Mhinduro:** Munogona kutibata nefoni, WeChat, kana email. Varongi vedu vevarwere vepasi rose vachakutungamirai mukuita musangano, kusanganisira kutumira zvinyorwa zvekurapa, kuronga kubvunzana vari kure, uye rubatsiro rwevhiza yekufamba kuenda kuChina.
**M: Marii yekurapa varwere vekune dzimwe nyika vari kurapwa kuChina?**
**M:** Mari yekurapwa inosiyana zvichienderana nemamiriro ezvinhu emunhu, kusanganisira mishonga yaunotora uye nguva yekurapwa. Mushure mekutaura nesu, tichakupa fungidziro yakadzama yemitengo zvichienderana nemamiriro ako chaiwo.
**M: Chipatara chinopa rubatsiro rwekubvunza varwere vari kure here?**
**Mhinduro:** Ehe, tinopa rubatsiro rwekuonana nevarwere vari kunze kwenyika vari kure, zvichikubvumidza kuti utange wakurukura nechikwata chedu chenyanzvi usati waenda kuChina kuti unzwisise hurongwa hwekurapa uye mhedzisiro inotarisirwa.
Nguva yekutumira: Kurume-04-2026